nafamostat has been researched along with linezolid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Hara, Y; Hasegawa, D; Kato, Y; Komura, H; Kuriyama, N; Matsumoto, K; Morita, K; Nakamura, T; Nishida, O; Shimomura, Y; Yamashita, C | 1 |
2 other study(ies) available for nafamostat and linezolid
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Nafamostat mesilate inhibits linezolid metabolism via its antioxidant effects.
Topics: Animals; Anti-Bacterial Agents; Anticoagulants; Benzamidines; Guanidines; Linezolid; Mice; Mice, Inbred C57BL; Models, Animal | 2020 |